The role of family therapy in the management of schizophrenia: challenges and solutions

Código QR

The role of family therapy in the management of schizophrenia: challenges and solutions

Alejandra Caqueo-Urízar,1,* Mar Rus-Calafell,2,* Alfonso Urzúa,3 Jorge Escudero,1 José Gutiérrez-Maldonado4 1Departamento de Filosofía y Psicología, Universidad de Tarapacá, Arica, Chile; 2Department of Social Psychiatry,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Caqueo-Urízar A, Rus-Calafell M, Urzúa A, Escudero J, Gutiérrez-Maldonado J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/03d49344d208462f962cdd3712eea8eb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
por: Pawelczyk T, et al.
Publicado: (2015)

Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia
por: Cai J, et al.
Publicado: (2015)

Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study
por: Gutiérrez-Fernández J, et al.
Publicado: (2015)

Defensive function of persecutory delusion and discrepancy between explicit and implicit self-esteem in schizophrenia: study using the Brief Implicit Association Test
por: Nakamura M, et al.
Publicado: (2014)

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
por: Alkhadhari S, et al.
Publicado: (2015)

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
por: Iancu I, et al.
Publicado: (2015)

Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms
por: Urban-Kowalczyk M, et al.
Publicado: (2015)

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
por: Masopust J, et al.
Publicado: (2015)

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
por: Yang X, et al.
Publicado: (2015)

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
por: Karthikeyan R, et al.
Publicado: (2014)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia
por: Fujiki R, et al.
Publicado: (2014)

The severe complication of Stevens–Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report
por: Wu MK, et al.
Publicado: (2015)

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
por: Kishi T, et al.
Publicado: (2014)

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
por: Cai SL, et al.
Publicado: (2015)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report
por: Noda Y, et al.
Publicado: (2014)

Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension
por: Amresh Shrivastava, et al.
Publicado: (2010)

Optimal management of night eating syndrome: challenges and solutions
por: Kucukgoncu S, et al.
Publicado: (2015)

Catatonia in Down syndrome; a treatable cause of regression
por: Ghaziuddin N, et al.
Publicado: (2015)

Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry
por: Willem MA Verhoeven, et al.
Publicado: (2010)

Efectos secundarios de la medicación antipsicótica y calidad de vida en pacientes con esquizofrenia latinoamericanos
por: Caqueo-Urízar,Alejandra, et al.
Publicado: (2017)

Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes
por: Qu M, et al.
Publicado: (2015)

The cost of schizophrenia in Japan
por: Sado M, et al.
Publicado: (2013)

Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
por: Babij R, et al.
Publicado: (2015)

Effect of depressive symptoms on the length of hospital stay among patients hospitalized for acute stroke in Japan
por: Sugawara N, et al.
Publicado: (2015)

Neuromodulation and antenatal depression: a review
por: Kim DR, et al.
Publicado: (2015)

Pharmacotherapy for treatment-resistant schizophrenia
por: Meghan E Mcilwain, et al.
Publicado: (2011)

Towards a framework for treatment effectiveness in schizophrenia
por: Juckel G, et al.
Publicado: (2014)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda A, et al.
Publicado: (2013)

Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women?
por: Celik Guzel E, et al.
Publicado: (2014)

Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder
por: Lamberti M, et al.
Publicado: (2015)

Minocycline as adjunct therapy for a male patient with deficit schizophrenia
por: Chen X, et al.
Publicado: (2018)

Social cognitive and neurocognitive deficits in inpatients with unilateral thalamic lesions — pilot study
por: Wilkos E, et al.
Publicado: (2015)

Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
por: Wang HR, et al.
Publicado: (2015)

Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study
por: Hsu YC, et al.
Publicado: (2015)

Profile of minocycline and its potential in the treatment of schizophrenia
por: Zhang L, et al.
Publicado: (2014)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka M, et al.
Publicado: (2014)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar F, et al.
Publicado: (2015)

Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia S, et al.
Publicado: (2012)